ODAC Recommends TICE BCG Approval For Recurrent Bladder Cancer Prevention
In Brief: Parkinson To Leave CTEP For Novartis; FTC To Permit Sandoz, Ciba-Geigy Merger
FDA News:: ODAC Commends Ciba For Design Of Trials Legal Issues:
US Appeals Court Dismisses Fisher’s Privacy Act Suit Supporting Femara
Breast Cancer: Working Group Sets Broad Agenda For Genetic Research
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- At AACR, Letai announces prevention and screening project for southern Appalachia, describes a future without paylines
There’s “clear evidence that funding is moving and the system is working.” - Forty years after Chernobyl: Little evidence to show that radiation released from the accident increased cancers globally
- UT Austin announces first tech-native academic medical center in the U.S.
- Long-awaited results from first phase III trial of a RAS inhibitor in pancreatic cancer shows that daraxonrasib doubles median OS
PanCAN’s Berkenblit: “It’s here. This is a tipping point, and we’ve tipped. And this is just the beginning.” - Problem: Misinformation and stigma prevent uptake of HPV vaccines and screening. Solution: A comic book









